Junya Kuroda

53PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesGene and molecular therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|May 28, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

|May 14, 2025
PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.

Noriko Fukuhara, Isao Yoshida, Takuro Ishiguro

|Oct 22, 2024
Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities.

Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto

|Aug 19, 2024
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63.

Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto

|May 25, 2024
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019.

Chie Yamamoto, Masashi Taniguchi, Keitaro Furukawa

|Apr 10, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi

Pageof 9

Frequent Collaborators

10 joint publications

Tsutomu Kobayashi

9 joint publications

Yuji Shimura

7 joint publications

Takahiro Fujino

6 joint publications

Dai Maruyama